• Carmen Phang Romero Casas, Rita de Cássia Ribeiro de Albuquerque, Rafaela Borge Loureiro, Angela Maria Gollner, Marina Gonçalves de Freitas, Graciela Paula do Nascimento Duque, and ViscondiJuliana Yukari KodairaJYKInstituto Butantã, Hospital Alemão Oswaldo Cruz (HAOC), São Paulo, SP, Brazil..
• Centro de Desenvolvimento Tecnológico em Saúde (CDTS), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil. Electronic address: carmen.romero@cdts.fiocruz.br.
• Clinics (Sao Paulo). 2022 Jan 1; 77: 100080100080.

AbstractEconomic assessments are relevant to support the decision to incorporate more cost-effective strategies to reduce Cervical Cancer (CC) mortality. This systematic review analyzes the economic evaluation studies of CC prevention strategies (HPV DNA-based tests and conventional cytology) in low- and middle-income countries. Medline, EMBASE, CRD, and LILACS were searched for economic evaluation studies that reported cost and effectiveness measures of HPV DNA-based tests for CC screening and conventional cytology in women, without age, language, or publication date restrictions. Selection and data extraction were carried out independently. For comparability of results, cost-effectiveness measures were converted to international dollars (2019). Report quality was assessed using the CHEERS checklist. The Dominance Matrix Ranking (DRM) was used to analyze and interpret the results. The review included 15 studies from 12 countries, with cost-effectiveness analyzes from the health system's perspective and a 3% discount rate. The strategies varied in age and frequency of screening. Most studies used the Markov analytical model, and the cost-benefit threshold was based on the per capita GDP of each country. The sensitivity analysis performed in most studies was deterministic. The completeness of the report was considered sufficient in most of the items evaluated by CHEERS. The Dominance Interpretation (DRM) varied; in 6 studies, the HPV test was dominant, 5 studies showed a weak dominance evaluating greater effectiveness of the HPV test at a higher cost, yet in 2 studies conventional cytology was dominant. Although the context-dependent nature of economic evaluations, this review points out the challenge of methodological standardization in the analytical models.Copyright © 2022 HCFMUSP. Published by Elsevier España, S.L.U. All rights reserved.

12 keywords...

hide…